within Pharmacolibrary.Drugs.ATC.S;

model S02BA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.02,
    Cl             = 5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.25 / 1000000,
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Fluocinolone acetonide is a synthetic corticosteroid with anti-inflammatory, anti-pruritic, and vasoconstrictive properties, primarily used topically to treat skin disorders like eczema, dermatitis, and psoriasis. It is also used in ophthalmic implants for certain eye conditions such as diabetic macular edema. The drug is approved and widely used in topical formulations.</p><h4>Pharmacokinetics</h4><p>No comprehensive published pharmacokinetic data could be found specific to fluocinolone acetonide in humans using clinical dosing in the literature. Available information is limited; absorption after topical administration is generally low, with minimal systemic exposure in healthy individuals.</p><h4>References</h4><ol><li><p>Spektor, Z, et al., &amp; Hedrick, J (2022). Pharmacokinetics of ciprofloxacin and fluocinolone acetonide otic solution in pediatric patients. <i>American journal of otolaryngology</i> 43(5) 103573–None. DOI:<a href=&quot;https://doi.org/10.1016/j.amjoto.2022.103573&quot;>10.1016/j.amjoto.2022.103573</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35988360/&quot;>https://pubmed.ncbi.nlm.nih.gov/35988360</a></p></li><li><p>Broggini, M, et al., &amp; Broccali, G (1991). Pharmacokinetics of fluocinolone acetonide in patch versus cream formulations. <i>International journal of clinical pharmacology research</i> 11(1) 17–21. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1874579/&quot;>https://pubmed.ncbi.nlm.nih.gov/1874579</a></p></li><li><p>Gao, HY, &amp; Li Wan Po, A (1994). Topical formulations of fluocinolone acetonide. Are creams, gels and ointments bioequivalent and does dilution affect activity?. <i>European journal of clinical pharmacology</i> 46(1) 71–75. DOI:<a href=&quot;https://doi.org/10.1007/BF00195919&quot;>10.1007/BF00195919</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8005190/&quot;>https://pubmed.ncbi.nlm.nih.gov/8005190</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S02BA08;
